Cefazolin: Clinical Trials

27 trials of Cefazolin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

15 completed, 5 unknown, 3 terminated, 1 active not recruiting. 27 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 327Completed 15, Unknown 5, Terminated 3, Active not recruiting 1, Not yet recruiting 1, Recruiting 1, Withdrawn 1
Phase 21Completed 1

Follow Cefazolin: new trials by email Literature Review of Cefazolin trials Research Report on Cefazolin

Trials (filtered) newest first · largest first

All 27 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of the Effect of Antibiotic Prophylaxis During Lumpectomy for Breast Cancer: Prospective Randomised Double-blind Noninferiority Study of Placebo vs Cefazolin
Cefazolin 2 g Infusion, Placebo infusion of .9 normal saline - Breast Cancer, Breast Surgery
Phase 3Not yet recruitingUniversity Hospital, Clermont-Ferrand16002026-11-012026-10-27
The Role of Antibiotic Prophylaxis in Lowering Wound Infection Rates Post-Open Repair of Primary Elective Groin Hernias in High-Risk Patients
Cefazolin 1000 MG - Antibiotic Prophylaxis, Wound Infection
Phase 3UnknownUniversity of Aleppo2002024-08-012024-08-28
Early Intravenous to Oral Antibiotic Switch in Uncomplicated Staphylococcus Aureus Bacteraemia
Tab. Trimethoprim-sulfamethoxazole, Tab. Clindamycin, Tab. Cephalexin, or Tab. Linezolid, IV Cloxacillin, IV Cefazolin, IV Vancomycin, or IV Ceftaroline - Staphylococcus Aureus Bacteremia
Phase 3UnknownClinical Research Centre, Malaysia2902024-06-282024-07-05
Local Antibiotics for Breast Implants
Gentamicin, Cefazolin and Vancomycin, Placebo - Implant Complication, Implant Infection
Phase 3Active not recruitingMikkel Herly10032021-01-272026-09-29
Antibioprophylaxis for Excision-graft Surgery in Burn Patient (A2B-TRIAL)
active intervention, placebo intervention - Burns Surgery
Phase 3RecruitingAssistance Publique - Hôpitaux de Paris5062020-10-112025-11-24
Results of Extended Versus Single Dose Antibiotic Prophylaxis In Orthopedic Revision Arthroplasty in Nijmegen.
Cefazolin - Infection Prosthesis Hip and Knee, Infection, Prosthesis Related
Phase 3UnknownRadboud University Medical Center7512019-01-012024-05-07
Peritonitis Prevention After Insertion of Peritoneal Dialysis Catheter.
Cefazolin - Peritoneal Dialysis-associated Peritonitis, Peritoneal Dialysis Catheter Infection
Phase 3UnknownCarmel Medical Center2002017-03-082023-02-13
Preventive Antibiotic Serum Levels During Caesarean Section
Blood samples., Cefazolin - Blood Antibiotic Levels
Phase 3UnknownTel-Aviv Sourasky Medical Center2502016-08-012016-07-20
Swiss PACK-CXL Multicenter Trial for the Treatment of Infectious Keratitis
PACK-CXL, Cefazolin in combination with either tobramycin or gentamicin, Cycloplegic agents (cyclopentolate 1% eye drops) - Keratitis; Infectious Disease (Manifestation)
Phase 3CompletedUniversity Hospital, Geneva352016-03-012020-10-20
Dalbavancin vs Comparator in Pediatric Subjects With Acute Hematogenous Osteomyelitis
Dalbavancin, cefazolin, nafcillin, oxacillin or vancomycin - Osteomyelitis
Phase 3WithdrawnDurata Therapeutics International BV (an Affiliate of Actavis, Inc.)2016-03-012016-09-23
Combination Antibiotic Therapy for Methicillin Resistant Staphylococcus Aureus Infection
Beta-Lactam - Methicillin-Resistant Staphylococcus Aureus
Phase 3TerminatedMenzies School of Health Research3582015-08-262018-12-19
Study of Tedizolid Phosphate in Adolescents With Complicated Skin and Soft Tissue Infection (cSSTI) (MK-1986-012)
Tedizolid Phophate, Antibiotic comparator, Aztreonam - Skin Diseases, Infectious, Skin Diseases, Bacterial
Phase 3CompletedCubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1202015-03-252019-08-07
Antibiotic Prophylaxis for HDR Brachytherapy in the Treatment of Prostate Cancer
Ciprofloxacin, Cefazolin - Prostate Cancer
Phase 3TerminatedCR-CSSS Champlain-Charles-Le Moyne1582015-02-102025-02-12
A Phase 3 Telavancin Staphylococcus Aureus (S. Aureus) Bacteremia Trial
Telavancin, Vancomycin, Daptomycin - Bacteremia
Phase 3TerminatedCumberland Pharmaceuticals1212014-12-012020-02-17
Trial of Randomized Antibiotic Administration in Percutaneous Nephrolithotomy
cephalosporins, Fluoroquinolones, Clindamycin - Kidney Stones
Phase 3CompletedNorthwell Health982014-09-012023-09-06
Staphylococcus Aureus Bacteremia Antibiotic Treatment Options
Trimethoprim-Sulfamethoxazole, Clindamycin, Linezolid - Staphylococcus Aureus Infection
Phase 3CompletedHeinrich-Heine University, Duesseldorf2152013-12-012020-05-27
Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY)
24-Hour Prophylactic Cefazolin* Antibiotic Regimen, 5-Days Prophylactic Cefazolin* Antibiotic Regimen - Infection, Bone Neoplasms
Phase 3CompletedMcMaster University6022013-01-012021-03-11
Duration of Antibiotics Treatment With Cefazolin and Clarithromycin in Women With Preterm Premature Rupture of Membrane
Cefazolin, Clarithromycin - Preterm Premature Rupture of Membrane
Phase 3CompletedSamsung Medical Center1512011-10-012022-04-20
Prevention of Arrhythmia Device Infection Trial (PADIT Pilot)
Cefazolin, Bacitracin, Cefalexin, Cefazolin - Arrythmias
Phase 3CompletedPopulation Health Research Institute5002009-12-012013-05-16
Effectiveness of Antibiotic Prophylaxis for Totally Implantable Venous Access Device
cefazolin Sodium, placebo - Solid Tumor
Phase 3CompletedIstanbul University1502008-09-012010-06-02

Showing 20 of 27. Sign in to see all of them.

Conditions studied

Infections (4)  ·  Surgical Wound Infection (4)  ·  Staphylococcal Infections (3)  ·  Bacteremia (2)  ·  Preterm Premature Rupture of the Membranes (2)  ·  Sepsis (2)  ·  Wound Infection (2)  ·  Bone Neoplasms (1)  ·  Breast Neoplasms (1)  ·  Cellulitis (1)  ·  Communicable Diseases (1)  ·  Emergencies (1)  ·  Fetal Membranes, Premature Rupture (1)  ·  Hemopneumothorax (1)  ·  Hernia, Inguinal (1)

Sponsors

Samsung Medical Center (2)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  CR-CSSS Champlain-Charles-Le Moyne (1)  ·  Carmel Medical Center (1)  ·  Clinical Research Centre, Malaysia (1)  ·  Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) (1)  ·  Cumberland Pharmaceuticals (1)  ·  Durata Therapeutics International BV (an Affiliate of Actavis, Inc.) (1)  ·  Heinrich-Heine University, Duesseldorf (1)  ·  Hospital Italiano de Buenos Aires (1)  ·  Istanbul University (1)  ·  McMaster University (1)  ·  MemorialCare (1)  ·  Menzies School of Health Research (1)  ·  Mikkel Herly (1)

Countries

United States (5)  ·  Canada (4)  ·  France (3)  ·  Netherlands (3)  ·  Argentina (2)  ·  Australia (2)  ·  Israel (2)  ·  Singapore (2)  ·  South Korea (2)  ·  Spain (2)  ·  Austria (1)  ·  Brazil (1)  ·  Denmark (1)  ·  Egypt (1)  ·  Germany (1)

Top investigators

Achim J Kaasch, MD (1)  ·  Alena Jamdourek, MD (1)  ·  Bart-Jan Kullberg, prof. Dr (1)  ·  Dr. Andrew Krahn (1)  ·  Farhad Hafezi, MD, PhD (1)  ·  Hasan Karanlik, MD (1)  ·  Jose M Cernadas, M.D. (1)  ·  Joshua Davis, MBBS, FRACP (1)  ·  Kenneth Chan, MD (1)  ·  Marc Garnier, MD, PhD (1)  ·  Marjory Jolicoeur, MD,MSc (1)  ·  Michelle Ghert, MD, FRCSC (1)

Results publications

PMID 21601826, PMID 23052809, PMID 26452342, PMID 27029920, PMID 30545448, PMID 31806127, PMID 32044943, PMID 32051007, PMID 32557558, PMID 33239101, PMID 33395210, PMID 33743753, PMID 33752752, PMID 34859113, PMID 34989778, PMID 34996516, PMID 36115667, PMID 36746334, PMID 37578113, PMID 38244557

NIH funding

2014 (1), 2025 (1)